Streptococcus pneumoniae surface non-capsular protein antigens

Streptococcus pneumoniae surface non-capsular protein antigens are a diverse group of conserved proteins located on the bacterial cell wall that play essential roles in pathogenesis and are primary targets for next-generation vaccines. Unlike the polysaccharide capsule, which is highly variable across more than 100 serotypes, these proteins are often broadly conserved across different strains, offering the potential for a universal pneumococcal vaccine. Key members of this group include Pneumococcal surface protein A (PspA), Pneumococcal surface protein C (PspC), and Pneumococcal histidine triad protein D (PhtD), which facilitate host cell adhesion, nutrient acquisition, and evasion of the host complement system. By inhibiting complement deposition and neutralizing antimicrobial peptides, these proteins allow the bacterium to survive in the bloodstream and colonize the nasopharynx. Therapeutic strategies, particularly vaccine development, focus on inducing high titers of opsonophagocytic antibodies that can neutralize these virulence factors and promote bacterial clearance. Clinical trials have evaluated various combinations of these proteins, such as bivalent PcpA-PhtD formulations, to overcome the limitations of current conjugate vaccines, such as serotype replacement and high production costs. These antigens are also critical for providing protection against non-encapsulated strains of S. pneumoniae, which are increasingly associated with mucosal infections like otitis media.

Other names

Pneumococcal surface proteinsNon-capsular antigensProtein-based pneumococcal vaccine antigensConserved pneumococcal surface proteinsPneumococcal virulence proteins

Induction of neutralizing antibodies and opsonophagocytic responses to prevent bacterial colonization and invasive disease.